M.J. Whiting
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Diabetes Treatment and Management 3
- Nephrology top 2%
- Surgery top 2%
- Pediatric Hepatobiliary Diseases and Treatments 3
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders 3
-
- Drug Transport and Resistance Mechanisms 11
-
- Gallbladder and Bile Duct Disorders 7
-
- Liver Disease Diagnosis and Treatment 4
-
- Drug Solubulity and Delivery Systems 3
- Co-authors
- Timothy M. E. DavisDavid SullivanR. John SimesPaul GlasziouJames D. BestY. Antero KesäniemiRussell ScottChristian Ehnholm
- Partner nations
- AustraliaNew ZealandFinland
In The Last Decade
M.J. Whiting
39 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 1.7k
- Nephrology 320
- Surgery 1.6k
- Cardiology and Cardiovascular Medicine 733
- Clinical Biochemistry 202
Countries citing papers authored by M.J. Whiting
This map shows the geographic impact of M.J. Whiting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Whiting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Whiting more than expected).
Fields of papers citing papers by M.J. Whiting
This network shows the impact of papers produced by M.J. Whiting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Whiting. The network helps show where M.J. Whiting may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.J. Whiting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2013 | 53 | |
| 3 | 2010 | 152 | |
| 4 | 2010 | 251 | |
| 5 | 2009 | 10 | |
| 6 | 2008 | 7 | |
| 7 | 2007 | 16 | |
| 8 | 1997 | 8 | |
| 9 | 1995 | 11 | |
| 10 | 1994 | 12 | |
| 11 | 1989 | 17 | |
| 12 | 1989 | 8 | |
| 13 | 1986 | 4 | |
| 14 | 1984 | 4 | |
| 15 | 1983 | 21 | |
| 16 | 1983 | 60 | |
| 17 | 1981 | 9 | |
| 18 | 1980 | 35 | |
| 19 | 1979 | 30 | |
| 20 | 1974 | 15 |
About M.J. Whiting
M.J. Whiting is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmaceutical Science and Clinical Biochemistry, having authored 39 papers that have together received 3.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Gallbladder and Bile Duct Disorders (7 papers), Liver Disease Diagnosis and Treatment (4 papers), Drug Solubulity and Delivery Systems (3 papers), Metabolism and Genetic Disorders (3 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Nephrology (320 citations) and Surgery (1.6k citations). M.J. Whiting has collaborated with scholars based in Australia, New Zealand and Finland. Frequent co-authors include Timothy M. E. Davis, David Sullivan, R. John Simes, Paul Glasziou, James D. Best, Y. Antero Kesäniemi, Russell Scott, Christian Ehnholm, Peter G. Colman and Avinesh Pillai. Their work appears in journals such as Gastroenterology, Clinica Chimica Acta, Gut, Diabetologia and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.